Misonix, Inc. announced that it has entered into an exclusive distribution agreement with Shandong Weigao Orthopedic Device Company Limited. The terms of the distribution agreement grant exclusive rights to Weigao Orthopedic for the sale, marketing and distribution of Misonix's BoneScalpel in the People's Republic of China, Hong Kong, and Macau for an initial period of five years.
Shandong Weigao Orthopaedic Device Co., Ltd
Equities
688161
CNE1000050W9
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.46 CNY | +0.17% | -5.78% | -43.40% |
Apr. 02 | Tranche Update on Shandong Weigao Orthopaedic Device Co., Ltd's Equity Buyback Plan announced on August 30, 2023. | CI |
Mar. 27 | Weigao Orthopaedic Device Names Chairman | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.40% | 1.29B | |
+71.87% | 12.28B | |
-19.76% | 8.08B | |
+15.96% | 7.23B | |
-6.42% | 5.29B | |
+4.54% | 4.93B | |
+18.62% | 4.19B | |
-21.30% | 4.13B | |
-40.48% | 2.24B | |
-3.47% | 2B |
- Stock Market
- Equities
- 688161 Stock
- News Shandong Weigao Orthopaedic Device Co., Ltd
- Misonix, Inc. Enters into Exclusive Chinese Distribution Agreement with Shandong Weigao Orthopedic Device Co., Ltd. for BoneScalpel